FindTrial
Sign In

Post-marketing clinical study on milnacipran hydrochloride

Post-marketing clinical study on milnacipran hydrochloride

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1080220060
Enrollment
Unknown
Registered
2005-09-08
Start date
2005-09-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, depressive states

Interventions

investigational material(s) Generic name etc : Milnacipran hydrochloride INN of investigational material : Therapeutic category code : 117 Psychotropic agents Dosage and Administration for Investigat

Sponsors

ASAHIKASEI PHARMA CORPORATION
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria 1)male or female patients aged 20 to 64 years; 2)patients who have been diagnosed with DSM-4 depressive disorders , etc. Exclusion criteria 1)patients with ischuria (such as prostatic disorders); 2)patients with glaucoma, etc.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Efficacy, safety—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026